期刊文献+

奥沙利铂联合多烯磷脂酰胆碱对胃癌细胞增殖影响研究 被引量:6

Effect of oxaliplatin combined with polyenephosphatidylcholine on proliferation of gastric cancer cells
原文传递
导出
摘要 目的:观察奥沙利铂联合多烯磷脂酰胆碱对胃癌细胞增殖的影响。方法:不同浓度奥沙利铂(0.5、1、2、4、8和16μmol/L)和多烯磷脂酰胆碱(2、4、8、16、32、64和128μmol/L)分别作用于胃癌细胞sGc790124、48和72h,MTT法检测各组肿瘤细胞的生存率。根据公式求出奥沙利铂48h的半抑制浓度(IC50),用略低于此浓度的奥沙利铂与不同浓度的多烯磷脂酰胆碱联合作用于胃癌细胞48h,MTT法检测细胞的生存率,计算2种药物联合的指数。结果:不同浓度的多烯磷脂酰胆碱对肿瘤细胞增殖产生了促进或者抑制作用,促进增殖或者抑制增殖作用与药物浓度具有明显相关性,F=373.769,P〈0.001;但与药物作用时间无明显统计相关,F=0.077,P=0.782。奥沙利铂抑制肿瘤增殖,这一作用也表现出明显的剂量=时间相关性,F-194.193,P〈0.001;F=12.428,P=0.001。联合作用组中,不同浓度的多烯磷脂酰胆碱与奥沙利铂联合较单药奥沙利铂相比,均对肿瘤细胞表现出现较高的抑制率,差异有统计学意义,F=297.889,P〈0.001;其中较低浓度多烯磷脂酰胆碱(2~8μmol/L)与奥沙利铂产生了协同抗肿瘤作用(Q〉1.15),高浓度多烯磷脂酰胆碱(32~128/μmool/L)与奥沙利铂发现拮抗反应(Q〈0.85)。结论:奥沙利铂抑制肿瘤细胞增殖,低浓度的多烯磷脂酰胆碱促进肿瘤细胞增殖,高浓度的多烯磷脂酰胆碱抑制肿瘤细胞增殖。奥沙利铂与低浓度多烯磷脂酰胆碱产生了协同抗肿瘤作用,与高浓度多烯磷脂酰胆碱却产生了拮抗抗肿瘤作用。 OBJECTIVE:To investigate the effect of combined oxaliplatin(L-OHP) and polyenephosphatidylcholine (PPC) on proliferation of gastric cancer cell line. METHODS:The proliferation rate of different concentrations of PPC and L-OHP on SGC7901 gastric cancer ceils for 24,48,72 hours were examined by MTT and then the half inhibitory concen tration (IC50) of L-OHP acting for 48 hours was calculated. SGC7901 cells were treated with oxaliplatin 3.5 μg/mL and PPC 0 to 128/μmol/L for 48 hours,then proliferation rates were determined by MTT assay and drug combination analysis were calculated according to the formula. RESULTS: MTT test results showed that different concentrations of PPC signifi cantly promoted or inhibited the proliferation of tumor cells,its role in the promoting of proliferation or inhibiting the pro liferation was drug concentration related (F=373. 769,P〈0. 001),but not drug-action time related(F=0.077,P= 0. 782). L-OHP inhibited tumor proliferation,its role also demonstrated dose(F= 194. 193, P(0. 001) -time(F= 12. 428, P= 0. 001)-related significantly. Compared with single-agent oxaliplatin, different concentrations of polyenephosphatidyl- choline combined with oxaliplatin all showed higher inhibition rates, the result was significant (F=297. 889, P〈0. 001); L-OHP and low concentrations of PPC(2--8/μmol/L) showed a synergistic anti-tumor effect (Q〉1 15)while L-OHP and high concentrations of PPC ( 32 - 128μmol/L) produced antagonism ( Q 〈0.85 ). CONCLUSIONS : L OHP has a clearantiproliferative effect on SGC7901 gastric cancer cells. Low concentrations of PPC promote tumor cell proliferation,while high concentrations of PPC inhibit tumor proliferation. When two drugs are combined, L-OHP and tow concentrations of PPC show a synergistic anti-tumor effect while L-OHP and high concentrations of PPC have produced antagonism.
出处 《中华肿瘤防治杂志》 CAS 北大核心 2014年第13期1010-1013,共4页 Chinese Journal of Cancer Prevention and Treatment
关键词 胃肿瘤 多烯磷脂酰胆碱 奥沙利铂 胃癌细胞SGC-7901 细胞增殖 stomach neoplasms polyene phoSphatidyl choline oxaliplatin gastric cancer cell SGC-7901 proliferation
  • 相关文献

参考文献13

二级参考文献87

  • 1金正均.合并用药中的相加[J].中国药理学报,1980,1:70-73.
  • 2KAWAHITO Y, KONDO M, TSUBOUCHI Y, et al. 1, 5-deoxy-(Delta) 12, 14-PGJ2 induces synoviocyte apoptosis and suppresses adjuvant- induced arthritis in rats[J]. J Clin In vest, 2000, 106(2): 189-197.
  • 3BISHOP B D. Hla t endothelial cell apoptosis induced by the peroxisome proliferator-activated receptor (PPAR) ligand 15-deoxy-delta 12, 14-prostaglandin J2[J]. Journal of Biological Chemistry, 1999, 274(24): 17042-17048.
  • 4MORRISON R F, FARMER S R. Role of PPARgamma in regulating a cascade expression of cyclin-dependent kinase inhibitors, p 18 (INK4c) and p21 (Waf1/Cip1) during adipogenesis[J]. Journal of Biological Chemistry, 1999, 274(24): 17088-17097.
  • 5CUI Y H, LU Z B, BAI L, et al. β -Carotene induces apoptosis and up- regulates perdxsome proliferator-activated receptor cexpressin and reactive oxygen specties production in MCF-7 cancer cells[J]. European Joural of Cancer, 2007, 43:2590-2601
  • 6SANO H, SARSFIAN T A, wilder, et al. Expression of cyclooxygenase- 1 and -2 on human colorectal cancer[J]. Cancer Res, 1995, 55: 3785- 3789.
  • 7KANE D J, SARAFIAN T A, ANTON R, et al. Bcl-2 inhibition of neural death: decreased generation of reactive oxygen spevies[J]. Science, 1993, 262: 1274-1277.
  • 8YANG J, LIU XS, BHALLA K, et al. Prevention of apoptosis by bcl-2: release of cytochrome c from mitochondria blocked[J]. Science, 1997, 275: 1129-1132.
  • 9SCHWARTZ J L. In vitro bilogical methods for deterination of deternination of carotenoid activity[J]. Methods Enzymol, 1993, 214: 226-256.
  • 10TOBA T, SHIDOJI Y, FUJII J, et al. Growth suppression and induction of heat-shock protein-70 by 9-cis- β -carotene in cervical dysplasia- derived cells[J]. Life Sci, 1997, 61: 839-845.

共引文献79

同被引文献84

  • 1张喜全,夏春光,万顺之.天晴甘美[J].中国新药杂志,2006,15(16):1409-1410. 被引量:36
  • 2孙燕,石远凯.临床肿瘤内科手册[M].北京:人民卫生出版社,2012:6.
  • 3戎强.邱晓梅.戎峰.126例原发性甲状腺功能亢进性肝损害临床分析[J].中国药物经济学,2013(5):413-414.
  • 4ABBOUD G,KAPLOWITZ N.Drug-induced liver injury[J].Drug Safety:an International Journal of Medical Toxicology and Drug Experience,2007,30(4):277-294.
  • 5ERIGUCHI M,OSADA I,FUJII Y,et al.Pilot study for preoperative administration of I-OHP to patients with ad- vanced scirrhous type gastric cancer[J].Biomedicine Phar- macotherapy*1997,51(5):217-220.
  • 6HAWTHORNE S,GALLAGHER S.Effects of glycyrrhetinic acid and liquorice extract on cell proliferation and prostate-spe- cific antigen secretion in LNCaP prostate cancer cells[J].The Journal of Pharmacy and Pharmacology,2008,60(5):661-666.
  • 7WAKAMATSU T,NAKAHASHI Y,HACHIMINE DAISAKU,et al.The combination of glycyrrhizin and lamivu- dine can reverse the cisplatin resistance in hepatocellular carci- noma cells through inhibition of multidrug resistance-associa- ted proteins[J].International Journal of Oncology,2007,31(6):1465-1472.
  • 8Mok TS, Wu Y, Thongprasert S, et al. Gefitinib or Carboplatin-Paclitaxel in Pulmonary Adenocarcinoma[J]. N Engl J Med, 2009,36,1(10): 947-57.
  • 9Wu SG, Yang CH, Yu CJ, et al. Good response to pemetrexed inpatients of lung adenocarcinoma with epidermal growth factorreceptor (EGFR) mutations[J]. Lung Cancer, 2011, 72(3): 333-9.
  • 10Chou TC. Drug combination studies and their synergy quantificationusing the Chou-Talalay method[J]. Cancer Res, 2010, 70(2):44,0-6.

引证文献6

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部